Related Experiment Video
Updated: Jul 6, 2026

A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats
Published on: November 6, 2018
Morphine-induced behavioral sensitization increased the mRNA expression of NMDA receptor subunits in the rat amygdala
Zargham Sepehrizadeh1, Mousa Sahebgharani, Shamseddin Ahmadi
1Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, University of Tehran, Tehran, Iran.
Abstract:
This study was designed to evaluate the effect of repeated morphine treatment on rat behavioral responses. In the genetic section, the mRNA expression of NMDA receptor subunits (NR1 and NR2A) was measured in certain areas of the male rat brain (striatum, prefrontal cortex, hippocampus, hypothalamus and amygdala). In the behavioral section, the effect of repeated morphine treatment on animal models such as locomotion, oral stereotypy, and state-dependent memory in a passive avoidance test was evaluated in the presence or absence of MK801 (NMDA receptor antagonist). Our results showed that chronic morphine treatment, followed by a 7-day (but not 24-hour) washout period, potentiated the effect of test doses of morphine, which is referred to as behavioral sensitization. Meanwhile, pretreatment of animals with MK801 (0.1 and 0.25 mg/kg), 30 min before a test dose of morphine (5 mg/kg), failed to attenuate the locomotion and oral stereotypy in the behavioral sensitization state. Interestingly, a higher dose of MK801 (0.25 mg/kg) decreased memory retrieval induced by morphine (2.5 mg/kg) in state-dependent memory. This effect may be due to the intrinsic motor enhancer property of higher doses of MK801, rather than the blockade of NMDA receptors. It can be concluded that MK801 does not affect morphine-induced behavioral sensitization in the expression phase. In the genetic section of the study, results of quantitative real-time RT-PCR clearly indicated that morphine sensitization increased the expression of NMDA receptor subunits mRNA in the amygdala (NR1 by 104% and NR2A by 85%), while the other areas of the brain were unaffected. Maenwhile, no change in the mRNA levels was observed in non-sensitized animals (chronic morphine treatment followed by a 24-hour washout period). In summary, the present study indicates that repeated morphine treatment followed by long-term (7-day washout) induces behavioral sensitization and causes a delayed increase in mRNA levels of NMDA receptor subunits in the rat amygdala. Meanwhile, it has previously been reported that the amygdala is involved in behavioral sensitization. Thus, it can be concluded that the increase in NMDA receptor expression is associated with morphine-induced behavioral sensitization.
Insights
Repeated morphine treatment induces behavioral sensitization in rats, increasing NMDA receptor mRNA in the amygdala. The NMDA receptor antagonist MK801 did not affect this sensitization but impacted memory retrieval.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Repeated morphine administration can lead to behavioral sensitization, a phenomenon where drug effects are potentiated.
- The N-methyl-D-aspartate (NMDA) receptor system is implicated in drug addiction and plasticity.
- Understanding the molecular mechanisms underlying morphine-induced behavioral sensitization is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the effect of repeated morphine treatment on rat behavior, focusing on locomotion, oral stereotypy, and state-dependent memory.
- To examine the role of the NMDA receptor antagonist MK801 in morphine-induced behavioral sensitization.
- To analyze the changes in mRNA expression of NMDA receptor subunits (NR1 and NR2A) in specific brain regions following chronic morphine exposure.
Main Methods:
- Rats received repeated morphine administration followed by washout periods of 24 hours or 7 days.
- Behavioral tests included locomotion, oral stereotypy, and a passive avoidance test for state-dependent memory.
- MK801, an NMDA receptor antagonist, was administered before test doses of morphine.
- Quantitative real-time RT-PCR was used to measure mRNA expression of NMDA receptor subunits in brain regions like the amygdala, striatum, prefrontal cortex, hippocampus, and hypothalamus.
Main Results:
- A 7-day washout period after chronic morphine treatment induced behavioral sensitization, potentiating responses to test doses of morphine.
- MK801 (0.1 and 0.25 mg/kg) did not attenuate locomotion or oral stereotypy in the sensitized state.
- Higher doses of MK801 impaired morphine-induced memory retrieval, potentially due to motor effects.
- Morphine sensitization significantly increased NR1 (104%) and NR2A (85%) mRNA expression in the amygdala, with no changes in other brain areas or in non-sensitized animals.
Conclusions:
- MK801 does not influence the expression phase of morphine-induced behavioral sensitization.
- Increased NMDA receptor subunit mRNA expression in the amygdala is associated with morphine-induced behavioral sensitization.
- The amygdala plays a role in the neurobiological underpinnings of morphine sensitization.
More Related Videos
Related Concept Videos
Opioid Receptors: Overview
Analgesia and Pain Management
Drug Abuse and Addiction: Pharmacological Phenomena

